Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mycronic AB's change in receivables for the quarter that ended in Jun. 2026 was $0.0 Mil. It means Mycronic AB's Accounts Receivable
stayed the same
from Mar. 2026 to Jun. 2026 .
Mycronic AB's change in receivables for the fiscal year that ended in Dec. 2025 was $-10.3 Mil. It means Mycronic AB's Accounts Receivable
increased by $10.3 Mil
from Dec. 2024 to Dec. 2025 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Mycronic AB's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 66.78.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Mycronic AB's liquidation value for the
three
months ended in Jun. 2026 was $87.1 Mil.
Mycronic AB (OTCPK:MICLF) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Mycronic AB's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mycronic AB Change In Receivables Related Terms
Mycronic AB Change In Receivables Historical Data
* Premium members only.
The historical data trend for Mycronic AB's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of $0.0 Mil mean?
Mycronic AB (MICLF) has a Change In Receivables of $0.0 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Mycronic AB and its competitors.
Is Mycronic AB's Change In Receivables too high?
Mycronic AB's current Change In Receivables is $0.0 Mil. Overall, Mycronic AB has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mycronic AB's Change In Receivables compare to GEV and ETN?
Mycronic AB's Change In Receivables of $0.0 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Industrial Products company?
A good Change In Receivables depends on the Industrial Products industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Mycronic AB and its competitors. Mycronic AB's current Change In Receivables is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mycronic AB stock overvalued right now?
Based on GuruFocus' analysis, Mycronic AB (MICLF) is currently considered Modestly Overvalued. The stock's GF Value™ is $25.01, compared to a current price of $32.50 — trading 29.9% above its estimated fair value. The current Change In Receivables is $0.0 Mil. Mycronic AB's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Mycronic AB (MICLF), the current Change In Receivables is $0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mycronic AB (MICLF) Overvalued in 2026?
Based on GuruFocus' analysis, Mycronic AB stock appears to be overvalued.
The current stock price of $32.50 is trading 29.9% above its estimated GF Value™ of $25.01.
GuruFocus considers Mycronic AB to be Modestly Overvalued.
Key valuation signals for MICLF:
Change In Receivables: $0.0 Mil
GF Value™: $25.01 vs. price of $32.50 (29.9% above fair value)
No single metric tells the full story. See the MICLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mycronic AB develops solutions for electronics production. It operates in four segments: Pattern Generators, which develops, manufactures, & markets mask writers & measuring machines for the production of photomasks for displays; The PCB Assembly Solutions division develops, manufactures, and markets flexible PCB assembly solutions, including jet printing, stencil printing, 3D inspection, component placement, and automated storage solutions. The High Volume division develops, manufactures, & markets equipment for dispensing and conformal coating of circuit boards, with a focus on high-volume markets in Asia. The Global Technologies division's offering includes production solutions with high levels of differentiation. The majority of its revenue is generated from the PCB Generators segment.
90GF Score
Get the complete analysis for MICLF
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MICLF has been successfully added to your 
